News Feb 14, 2024 University of Fribourg discovers drug to combat age-related neuroinflammation Scientists at the University of Fribourg have uncovered a groundbreaking mechanism that could significantly mitigate age-related neuroinflammatio...
News Nov 23, 2023 Friderici Spécial and Qaptis team up to pioneer CO2 capture in heavy transport In a landmark move for sustainable transport, EPFL spin-off Qaptis has joined forces with road transport leader Friderici Spécial.
News Nov 22, 2023 A new material from EPFL to cut 500 million tons of emissions by 2030 A new material developed at EPFL, called LC3, could change the way we make cement forever.
News Nov 03, 2023 EPFL and Novochizol to collaborate on designing more efficient immunotherapies A groundbreaking collaboration between EPFL's Laboratory of Biomaterials for Immunoengineering and Novochizol aims to revolutionize cancer treatm...
Rapport sectoriel Mar 01, 2024 L’Italie renouvelle les incitations pour les investissements dans l’industrie 4.0 Les entreprises italiennes qui investissent dans les technologies de l'industrie 4.0 peuvent bénéficier d'incitations substantielles. Ce petit gu...
Branchenreport Mar 07, 2024 Italien verlängert seine Anreizprogramme für Investitionen in Industrie 4.0 Italienische Unternehmen, die in Industrie-4.0-Technologie investieren, können erhebliche Zuschüsse erhalten. Dieser kurze Leitfaden über das Anr...
Branchenreport Jan 09, 2023 Der Eisenbahnsektor in Marokko: Welche Chancen bietet er? Das marokkanische Eisenbahnnetz zählt heute zu den modernsten in Afrika. Das staatliche Eisenbahnverkehrs- und -infrastrukturunternehmen, Office ...
Rapporti settoriali Mar 01, 2024 L’Italia rinnova i suoi incentivi per gli investimenti nell’Industria 4.0 Le aziende italiane che investono nella tecnologia di Industria 4.0 possono ottenere consistenti incentivi. Una breve guida sullo schema degli in...
News Oct 10, 2023 HES-SO Valais-Wallis and Debiopharm partner up to battle cancer HES-SO Valais-Wallis and Debiopharm have entered a partnership to advance targeted cancer therapy research with novel antibody conjugates.
News Sep 14, 2023 Swiss electric racing car breaks world record An electric racing car built by students of the Swiss Federal Institute of Technology in Zurich and the Lucerne University of Applied Sciences an...
News Jul 04, 2023 Top Stories from Western Switzerland (April-June 2023) From space exploration to medical breakthroughs and advancements in education and industry, discover Western Switzerland's top stories from April...
Industry Report Mar 07, 2024 Italy renews its incentives for industry 4.0 investments Italian companies who invest in industry 4.0 technology can get substantial incentives. A short guide about the incentive scheme might help you i...
News Apr 19, 2023 The University of Bern flies to Jupiter to uncover signs of life The University of Bern plays a significant role in the ESA’s JUICE mission, which started its journey to Jupiter on 14 April 2023, and will searc...
Industry Report Dec 28, 2022 Rail sector in Morocco: a land of opportunity Morocco’s rail network is currently one of Africa’s most modern networks. The Moroccan National Railways Office (ONCF) has launched a very ambiti...
News Feb 20, 2023 Limula and CSEM collaborate to make cellular therapies more accessible To improve the accessibility of cellular therapies using automation, Limula has received support from the CSEM from the prototyping phase to the ...
News Jan 18, 2023 M2C, a unique platform for advanced manufacturing technologies in Neuchâtel In Neuchâtel, the Micromanufacturing Science & Engineering Center offers a unique ecosystem for advanced and additive manufacturing technologies ...
News Dec 19, 2022 Lonza uses virtual reality to train and attract talented workers Lonza's Visp site has developed a training tool that uses virtual reality. To this day, more than 250 people have been trained using this new tec...